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Background
Of the roughly 40 million people 
living with HIV [1], an estimated 
6 million in developing countries 
urgently need life-saving antiretroviral 
therapy (ART) [2]. Yet when the 3 by 
5 Initiative was launched by the World 
Health Organization (WHO) and the 
Joint United Nations Programme on 
HIV/AIDS (UNAIDS) in December 
2003—an initiative that aims to treat 3 
million people with HIV in developing 
countries with ART by the end of 
2005—most people with HIV in these 
countries did not even know their HIV 
status, and less than 8% were receiving 
ART. Moreover, even the success of the 
initiative would still mean that fewer 
than half of the people who could 
beneﬁ  t from such treatment would be 
receiving it. 
Given this gap between what can 
be done and what needs to be done, 
the people who set policies and 
administer programs to provide ART 
in high-burden countries are faced 
with difﬁ  cult questions of distributive 
justice. Decisions regarding the pricing 
of ARTs and other care for patients 
with HIV/AIDS, the distribution 
of treatment centers, and potential 
measures to overcome barriers for 
vulnerable populations will determine 
who will get access to treatment and 
who will die. In order to deal with these 
crucial issues, decision-makers need 
guidance on how to design policies on 
equitable access to ART that respect 




A new study by Wilson and Blower, 
published in the February issue 
of PLoS Medicine [3], addresses an 
important dimension of equity in AIDS 
treatment, namely, the accessibility 
of health facilities to persons in need. 
Most published measures of spatial 
accessibility to health care can be 
classiﬁ  ed into four categories based on 
the measure of accessibility they use: 
provider-to-population ratios, distance 
to nearest provider, average distance 
to a set of providers, and gravitational 
(which shows the potential interaction 
between any population point and 
all service points within a reasonable 
distance) [4]. Wilson and Blower 
developed a mathematical model of 
the last type that could inform policy-
makers’ decisions regarding the 
optimal distribution of treatment sites 
to ensure equal access by all individuals 
infected with HIV. Applying this tool 
to the South-African province of 
KwaZulu–Natal, Wilson and Blower 
were able to conﬁ  rm mathematically 
the intuitive assumption that using 
a maximum number of centers, at 
the least possible distance from most 
affected populations, would lead to the 
greatest fairness in the geographical 
distribution of ART. 
Strengths and Weaknesses 
of the Study
While the authors suggest that their 
method could be adapted to take other 
objectives into account, here they 
have taken an exclusively egalitarian 
approach to equity. Although this 
notion of equity is broadly accepted, 
other important approaches could 
have been taken into consideration. 
Simple equality in access can actually 
produce inequities (because a fair 
approach would differentiate among 
groups in the population according to 
their different needs); further, under 
some theories, those who are least 
advantaged generally should receive 
a disproportionate share of newly 
distributed beneﬁ  ts (the maximin 
principle) [5]. In geographic terms, 
this goal could be reached by setting 
up treatment sites preferentially in 
neglected rural areas or urban slums. 
Conversely, utilitarian ethics would 
favor locating treatment sites so as 
to maximize overall beneﬁ  ts to the 
population, such as by concentrating 
treatment in already existing sites that 
could scale up treatment volume at the 
lowest cost per patient.
In determining equitable spatial 
accessibility for the application of their 
model to KwaZulu–Natal, the authors 
used a rather rough estimation of 
HIV prevalence (13% in urban areas 
and 9% in rural areas). As prevalence 
greatly varies between speciﬁ  c 
communities, future studies would 
certainly beneﬁ  t from using more 
disaggregated data where available 
(see, for example, [6]). Similarly, as 
the authors recognize, the geographic 
accessibility of treatment not only is 
a function of distance, but may be 
strongly inﬂ  uenced by other factors, 
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Figure 1. Steps to Equitable Access—The Policy Development Cycle at a Glance
IDU, intravenous drug user; NGO, non-governmental organization; PLWHA, people living with HIV/AIDS. (Source: [9])
March 2005  |  Volume 2  |  Issue 3  |  e69PLoS Medicine  |  www.plosmedicine.org 0194
such as available transportation 
options. The concept of “catchment 
regions” is a valuable one, though still 
a factor of great uncertainty. Further 
research is needed to examine the 
ability and willingness of patients with 
HIV to travel, taking into account 
factors such as disease stage, travel 
times and transportation prices, and 
socioeconomic factors. 
Place matters, but spatial accessibility 
is only one factor to be overcome in 
ensuring equitable access to health 
services. Studies show that even when 
services are available at a near distance, 
factors such as temporal accessibility, 
disease perception, stigmatization, 
and outright discrimination heavily 
inﬂ  uence “effective demand” [7]. 
Moreover, several studies have shown 
that the price of ARTs may be one 
of the greatest barriers to access and 
adherence [8], as even small fees at 
point of service can prove prohibitive 
for many people.
The Future
Wilson and Blower have developed a 
mathematical model to determine the 
fair geographical distribution of ART 
treatment sites and have applied it to 
the speciﬁ  c setting of KwaZulu–Natal. 
Despite some methodological and data 
limitations, such studies can inform 
policy-makers’ decisions regarding 
the location of HIV services. Since 
distance to a treatment center is 
strongly determinant of patients’ ability 
to access care, WHO is developing 
a service availability mapping tool 
to monitor relative equity between 
districts and identify major gaps 
in service availability, for example, 
availability of ART and prevention of 
mother-to-child transmission programs.
Not only is further research needed 
to reﬁ  ne the spatial accessibility model 
presented by the authors but careful 
attention must be paid to other factors 
that affect access to HIV services and 
to the underlying assumptions as to 
what would constitute fair distribution. 
In a recent guidance document, 
WHO and UNAIDS recommended 
that ART programs include special 
measures to ensure access of vulnerable 
and marginalized populations and 
women to ART [9]. The decision-
making processes regarding who will 
get treatment and who won’t must be 
closely monitored for transparency and 
inclusiveness. Evaluators should also be 
able to determine the extent to which 
the scaling-up of HIV/AIDS programs 
are reaching the target populations 
and producing equitable results (see 
Figure 1). To ensure that this process is 
robust and evenhanded, the guidance 
document recommends that national 
AIDS commissions and programs 
appoint ethics advisory bodies. These 
ethics committees are to make sure 
that issues of equity receive attention 
alongside technical considerations, such 
as the manner in which ART programs 
are integrated into the general health 
system and the identiﬁ  cation and 
training of health personnel, whose 
absence is often the greatest barrier to 
adequate HIV care [10].  
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